Professional Advisory Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Hold
1,450
0.03% 87
2026
Q1
$221K Hold
1,450
0.03% 78
2025
Q4
$200K Buy
+1,450
New +$190K 0.03% 79
2023
Q3
Sell
-2,630
Closed -$265K 70
2023
Q2
$265K Hold
2,630
0.04% 63
2023
Q1
$242K Sell
2,630
-150
-5% -$13.1K 0.04% 69
2022
Q4
$252K Buy
+2,780
New +$234K 0.04% 66
2022
Q2
Sell
-2,627
Closed -$231K 76
2022
Q1
$231K Sell
2,627
-276,159
-99% -$23.9M 0.03% 73
2021
Q4
$24.4M Buy
278,786
+11,007
+4% +$914K 3.32% 12
2021
Q3
$21.9M Buy
267,779
+19,077
+8% +$1.72M 3.22% 16
2021
Q2
$22.7M Buy
248,702
+2,846
+1% +$253K 3.29% 12
2021
Q1
$21M Buy
245,856
+17,885
+8% +$1.6M 3.22% 16
2020
Q4
$21.5M Buy
227,971
+3,884
+2% +$339K 3.46% 9
2020
Q3
$19.5M Buy
224,087
+19,982
+10% +$1.73M 3.48% 11
2020
Q2
$17.8M Buy
204,105
+3,520
+2% +$304K 3.43% 12
2020
Q1
$16.5M Sell
200,585
-2,369
-1% -$211K 3.84% 10
2019
Q4
$19.2M Buy
202,954
+4,780
+2% +$429K 3.42% 11
2019
Q3
$17.2M Sell
198,174
-1,050
-0.5% -$94.3K 3.27% 14
2019
Q2
$18.2M Sell
199,224
-41,074
-17% -$3.48M 3.53% 10
2019
Q1
$20.7M Sell
240,298
-1,620
-0.7% -$130K 4.16% 2
2018
Q4
$18.6M Sell
241,918
-20,777
-8% -$1.62M 4.14% 2
2018
Q3
$20.3M Sell
262,695
-6,577
-2% -$486K 4% 2
2018
Q2
$18.2M Buy
269,272
+25,042
+10% +$1.73M 3.76% 7
2018
Q1
$17.7M Sell
244,230
-1,019
-0.4% -$77.6K 3.83% 6
2017
Q4
$18.5M Sell
245,249
-1
-0% -$75 3.89% 7
2017
Q3
$18.9M Sell
245,250
-4,442
-2% -$335K 4.02% 3
2017
Q2
$18.7M Sell
249,692
-12,955
-5% -$918K 4.05% 2
2017
Q1
$17.5M Sell
262,647
-3,566
-1% -$238K 3.87% 5
2016
Q4
$17.4M Buy
266,213
+33,175
+14% +$2.15M 4.04% 5
2016
Q3
$16.5M Sell
233,038
-54
-0% -$3.94K 3.76% 7
2016
Q2
$17.2M Buy
233,092
+2,339
+1% +$162K 3.94% 4
2016
Q1
$15M Buy
230,753
+26,590
+13% +$1.81M 3.54% 10
2015
Q4
$15.7M Buy
204,163
+67,562
+49% +$5.37M 3.76% 11
2015
Q3
$11.3M Sell
136,601
-50,775
-27% -$4.52M 2.82% 17
2015
Q2
$16.5M Sell
187,376
-1,198
-0.6% -$110K 3.96% 7
2015
Q1
$16.7M Buy
188,574
+37,801
+25% +$3.35M 4% 6
2014
Q4
$12.5M Sell
150,773
-232
-0.2% -$19.2K 2.92% 18
2014
Q3
$12.7M Sell
151,005
-633
-0.4% -$51.2K 3.08% 14
2014
Q2
$12.3M Sell
151,638
-62,801
-29% -$4.94M 2.99% 15
2014
Q1
$16.3M Sell
214,439
-8,794
-4% -$641K 4.08% 5
2013
Q4
$16.1M Sell
223,233
-1,483
-0.7% -$103K 4.18% 6
2013
Q3
$15.4M Buy
224,716
+1,241
+0.6% +$82.1K 4.36% 3
2013
Q2
$14.2M Buy
+223,475
New +$14.5M 4.23% 6

Other funds holding NVS

Professional Advisory Services's NVS Position: Q2 2026 in Review

Professional Advisory Services held its Novartis (NVS) position steady in Q2 2026 at 1,450 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #87.

Professional Advisory Services first reported a position in NVS in Q2 2013 and has held it in 42 quarters since. The position peaked at $24.4M in Q4 2021. 325 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Professional Advisory Services held 1,450 shares of Novartis worth $227K as of Q2 2026.
  • Professional Advisory Services left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.03% of Professional Advisory Services's portfolio in Q2 2026, its #87 holding.
  • Professional Advisory Services first reported a position in Novartis in Q2 2013 and has held it in 42 quarters since.
  • Professional Advisory Services's Novartis position peaked at $24.4M in Q4 2021.
  • 325 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.